Reading ASPN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ASPN free→Reading ASPN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ASPN free→QuarterlyIQ Insights · ASPN
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 13, 2026, the Board of Directors of Aspen Aerogels, Inc. (the “Company”) designated Grant Thoele as the Company’s principal accounting officer, effective immediately, in addition to his current roles as the Company’s Chief Financial Officer, Treasurer and principal financial officer. Mr. Thoele assumed the responsibilities of principal accou…
Results of Operations and Financial Condition. On May 7, 2026, Aspen Aerogels, Inc. announced its financial results for the first quarter of 2026, which ended March 31, 2026, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the headings “Financial Outlook” and “About Aspen Aerogels, Inc.,” together with the forward-loo…
Results of Operations and Financial Condition. On February 25, 2026, Aspen Aerogels, Inc. announced its financial results for the fourth quarter and fiscal year 2025, which ended December 31, 2025, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the headings “Financial Outlook” and “About Aspen Aerogels, Inc.,” togeth…
Entry into a Material Definitive Agreement. On December 16, 2025, Aspen Aerogels, Inc., a Delaware corporation (the “ Company ”), Aspen Aerogels Rhode Island, LLC, a Rhode Island limited liability company (“ Aspen RI ”), Aspen Aerogels Mexico Holdings, LLC, a Delaware limited liability company (“ Aspen Mexico ”) and Aspen Aerogels Georgia, LLC, a Georgia limited liability company (“ Aspen Georgia ” and, together with the Company, Aspen RI and Aspen Mexico, collectively, the “ Credit Parties ”…
Results of Operations and Financial Condition. On November 6, 2025, Aspen Aerogels, Inc. announced its financial results for the third quarter of 2025, which ended September 30, 2025, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the headings “2025 Financial Outlook” and “About Aspen Aerogels, Inc.,” together with t…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously announced, Aspen Aerogels, Inc. (the “Company”) is promoting Grant Thoele to the position of Chief Financial Officer and Treasurer, effective October 1, 2025, succeeding the Company’s current Chief Financial Officer and Treasurer, Ricardo C. Rodriguez. In connection with Mr. Thoele’s promotion, on September 5, 2025, the Compensation a…
Results of Operations and Financial Condition. On August 7, 2025, Aspen Aerogels, Inc. announced its financial results for the second quarter of 2025, which ended June 30, 2025, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the headings “Second Half of 2025 Financial Outlook,” “Aspen Announces CFO Transition to Inte…
Results of Operations and Financial Condition. On May 8, 2025, Aspen Aerogels, Inc. announced its financial results for the first quarter of 2025, which ended March 31, 2025, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the heading “Q2 2025 Financial Outlook” and under the heading “About Aspen Aerogels, Inc.,” toge…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan The stockholders of Aspen Aerogels, Inc. (the “Company”) approved the Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan (the “2023 Plan”) at the 2025 Annual Meeting of Stockholders of the Company (the “Annual Meeting”) held on April 30, 2025. The 2023 Plan was previously ap…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 5, 2025, the Board of Directors (the “Board”) of Aspen Aerogels, Inc. (the “Company”), upon the recommendation of its Compensation and Leadership Development Committee, approved the grant of a performance share unit award to Donald R. Young, President and Chief Executive Officer, and on March 4, 2025, the Compensation and Leadership Develo…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 4, 2025, Rebecca B. Blalock and Mark L. Noetzel notified the Board of Directors (the “Board”) of Aspen Aerogels, Inc. (the “Company”) of their intention to retire from the Board effective immediately after the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”) scheduled to be held on April 30, 2025, as part of the Company…
Results of Operations and Financial Condition. On February 12, 2025, Aspen Aerogels, Inc. announced its financial results for the fourth quarter and fiscal year 2024, which ended December 31, 2024, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the heading “Q1 2025 Financial Outlook” and under the heading “About Aspe…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.